Overview
Connor Lang-Morgan practices practicing medicine in Vancouver, Canada.
His clinical expertise encompasses N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3.
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Connor Lang-Morgan
Is Connor Lang-Morgan a top-rated expert for N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3?
MediFind is an objective health platform that identifies experts based on real-world data. Connor Lang-Morgan is classified as an Experienced expert for N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Connor Lang-Morgan participate in research or clinical trials?
Yes. Connor Lang-Morgan has published 20 articles and abstracts on conditions like N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3. You can view a list of Connor Lang-Morgan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3